(PSD) November 2014 PBAC Meeting

advertisement
Public Summary Document – November 2014 PBAC Meeting
14.3 MINOR LISTINGS AND CHANGES TO LISTINGS PROCESSED
BY THE SECRETARIAT
GLUCOSE INDICATOR BLOOD
Glucose indicator blood strip: diagnostic, 100
Dario® Blood Glucose Test Strip, uHealth Australia Pty Ltd
1
Purpose of application
1.1
To request listing of a new form of blood glucose test strips.
2
Requested listing
2.1
The submission did not propose a requested listing for Dario® Blood Glucose Test
Strip. Listing of Dario® blood glucose test strips under the same conditions as
currently PBS-listed blood glucose test strips is considered appropriate.
2.2
The submission requested the same price as other currently PBS-listed equivalent
comparators.
3
PBAC outcome
3.1
The PBAC recommend listing under the same conditions as currently listed
PBS-listed blood glucose test strips.
4
Recommended listing
Name, Restriction,
Max.
Manner of administration and form
Qty (Packs)
GLUCOSE INDICATOR BLOOD
glucose indicator blood strip: diagnostic, 1
100 diagnostic strips
Category /
Program
Prescriber type:
Max.
Qty (Units)
No. of
Rpts
Proprietary Name and
Manufacturer
100
5
Dario® Blood
Glucose Test
Strip
uHealth
Australia
GENERAL – General Schedule (Code GE)
Dental
Medical Practitioners
Midwives
1
Nurse practitioners
Optometrists
Public Summary Document – November 2014 PBAC Meeting
Name, Restriction,
Manner of administration and form
GLUCOSE INDICATOR BLOOD
Max.
Qty (Packs)
glucose indicator blood strip: diagnostic, 1
100 diagnostic strips
Category /
Program
Prescriber type:
Max.
Qty (Units)
No. of
Rpts
Proprietary Name and
Manufacturer
100
11
Dario® Blood
Glucose Test
Strip
uHealth
Australia
GENERAL – General Schedule (Code GE)
Condition:
Dental
Medical Practitioners
Midwives
Blood glucose monitoring
PBS Indication:
Blood glucose monitoring
Restriction Level / Method:
Restricted benefit
Authority Required - In Writing
Authority Required - Telephone
Authority Required – Emergency
Authority Required - Electronic
Streamlined
Patient must be receiving treatment under a GP Management Plan or Team
Care Arrangements where Medicare benefits were or are payable for the
preparation of the Plan or coordination of the Arrangements.
No increase in the maximum quantity or number of units may be authorised.
No increase in the maximum number of repeats may be authorised.
Clinical criteria:
Administrative Advice
5
Nurse practitioners
Optometrists
Context for Decision
The PBAC helps decide whether and, if so, how medicines should be subsidised in
Australia. It considers submissions in this context. A PBAC decision not to
recommend listing or not to recommend changing a listing does not represent a final
PBAC view about the merits of the medicine. A company can resubmit to the PBAC
or seek independent review of the PBAC decision.
6
Sponsor’s Comment
The Sponsor had no comment.
2
Download